v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Cash flows from operating activities    
Net income $ 350.7 $ 194.2
Adjustments to reconcile net income to net cash provided by operating activities:    
Share-based compensation for equity-based awards 294.3 271.0
Deferred income taxes (137.4) (0.3)
Depreciation and amortization 83.9 64.3
Amortization of deferred contract costs 110.4 105.5
Amortization of debt issuance costs 0.5 1.0
Change in fair value of contingent consideration liability 6.3 0.0
Reduction of operating lease right-of-use assets 16.0 12.4
Amortization of investment premiums, net of accretion of purchase discounts (15.0) (14.7)
Changes in operating assets and liabilities, net of effects of acquisitions:    
Accounts receivable, net 1,485.7 1,050.2
Financing receivables, net 10.7 (43.6)
Deferred contract costs (78.9) (63.3)
Prepaid expenses and other assets (3.6) 54.0
Accounts payable 96.8 (0.4)
Accrued compensation (200.2) (216.9)
Accrued and other liabilities (94.0) (33.8)
Deferred revenue (416.6) 146.4
Net cash provided by operating activities 1,509.6 1,526.0
Cash flows from investing activities    
Purchases of investments (660.0) (854.7)
Proceeds from sales of investments 291.3 304.6
Proceeds from maturities of investments 369.0 457.9
Business acquisitions, net of cash and restricted cash acquired (500.0) 0.0
Purchases of property, equipment, and other assets (44.1) (36.8)
Net cash used in investing activities (543.8) (129.0)
Cash flows from financing activities    
Repayments of convertible senior notes (319.0) (46.0)
Repurchases of common stock 0.0 (66.7)
Proceeds from sales of shares through employee equity incentive plans 120.7 86.4
Payments for taxes related to net share settlement of equity awards (21.4) (15.5)
Net cash used in financing activities (219.7) (41.8)
Net increase in cash, cash equivalents, and restricted cash 746.1 1,355.2
Cash, cash equivalents, and restricted cash - beginning of period 1,546.8 1,142.2
Cash, cash equivalents, and restricted cash - end of period 2,292.9 2,497.4
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets    
Cash and cash equivalents 2,282.8 2,491.4
Restricted cash included in prepaid expenses and other current assets 10.1 6.0
Total cash, cash equivalents, and restricted cash 2,292.9 2,497.4
Non-cash investing and financing activities    
Contingent consideration for a business acquisition $ (648.9) $ 0.0